THE EFFECT OF GLUCOSE PRETREATMENT ON THE ANTI-TUMOUR ACTION OF MANNITOL MYLERAN.
D001002:Anuria; D001127:Arginine Vasopressin; D001769:Blood; D002066:Busulfan; D002845:Chromatography; D003124:Colorimetry; D005441:Fluids and Secretions; D005947:Glucose; D006982:Hypertonic Solutions; D008353:Mannitol; D008660:Metabolism; D009369:Neoplasms; D010600:Pharmacology; D051381:Rats; D012106:Research; D012965:Sodium Chloride; D013012:Sorbitol; D014265:Triethylenemelamine; D014556:Urine; D014667:Vasopressins
D006982:Hypertonic Solutions; D014667:Vasopressins; D001127:Arginine Vasopressin; D008353:Mannitol; D012965:Sodium Chloride; D013012:Sorbitol; D014265:Triethylenemelamine; D002066:Busulfan; D005947:Glucose
ANURIA; BLOOD; BUSULFAN; CHROMATOGRAPHY; COLORIMETRY; EXCRETION; EXPERIMENTAL LAB STUDY; GLUCOSE; HYPERTONIC SOLUTIONS; MANNITOL; METABOLISM; PHARMACOLOGY; RATS; SODIUM CHLORIDE; SORBITOL; TRIETHYLENE MELAMINE; URINE; VASOPRESSIN